Understanding the Four Major Types of Dementia and Why Accurate Diagnosis Matters

Dementia is a word that often sparks fear and confusion, with many families immediately thinking of Alzheimer’s as the only form. But dementia is actually an umbrella term for several distinct diseases, each with its own causes, symptoms, treatments, and risks. In this episode of "What I'd Tell My Family," Dr. Todd Levine guides us through the essential differences between the four major types of dementia: Alzheimer's disease, Lewy body dementia, frontotemporal dementia, and vascular dementia. We'll explore how new diagnostic tools and FDA-approved treatments are making precision medicine possible, learn about the frequently missed or misdiagnosed forms like Lewy body dementia, and discover why getting the right diagnosis has never been more important. Whether you’re noticing early memory slips in a loved one or want to prepare for the future, Dr. Levine offers practical advice, discusses life-changing medication risks, and explains the importance of new biomarkers that could change how we fight these diseases. If you think all dementias are the same, this episode will give you the critical distinctions every family needs to know. Timestamps: 00:00 Precision medicine in dementia care 04:40 Understanding Alzheimer's protein buildup 07:15 Understanding brain aging stages 11:09 Understanding Dementia with Lewy Bodies 16:38 Aggression in frontotemporal dementia 19:39 Addressing Cognitive Decline Risks 22:26 Understanding co-pathology in dementia 23:54 Precision medicine for dementia treatment 28:25 Diagnosing neurological conditions over time 32:20 Early diagnosis and intervention 33:35 Advancements in Alzheimer's diagnostics Quotes, Hooks, & Timestamps: "But in order for us to get to the place where we can treat patients as individuals, we need to be able to know what is actually causing their loss of cognitive function." — Dr. Todd Levine [00:03:04 → 00:03:15] "And so one of the earliest symptoms in Alzheimer's disease is people having trouble with short term memories." — Dr. Todd Levine [00:05:42 → 00:05:49] "So one of the things that people notice early on, actually, are hallucinations, both visual meaning what they see, or auditory meaning what they hear. This can occur very early in the disease course." — Dr. Todd Levine [00:10:32 → 00:10:45] "Many people may not be aware, but probably the most famous case of this recently was Robin Williams, and that's what he died from." — Dr. Todd Levine [00:11:44 → 00:11:53] "In vascular dementia, because they're actually having little strokes in their brain, they often have what's called a stepwise progression. So, yes, if you look back a year ago, there were. But you might actually say, oh, at the beginning of June, they could do X, but then all of a sudden, they couldn't do X anymore. It seems to be very sudden, the changes, because what's happening is a part of the brain has died, and then the loss of that part of the brain causes a very sudden change in their cognition." — Dr. Todd Levine [00:21:10 → 00:21:44] "about 30 or 40% of the time a person with Alzheimer's disease will also have the same proteins as dementia with Lewy bodies. And about 40% of the time, a person with dementia with Lewy bodies will have the same proteins as Alzheimer's disease." — Dr. Todd Levine [00:23:21 → 00:23:36] "I think dementia may be very much like that as well, which once we start to have better ways to, to know and diagnose the type of dementia, then we can develop specific medications for each type." — Dr. Todd Levine [00:23:54 → 00:25:02] "if I see someone today, if I could magically know what they're going to be like in 10 years, if I had that long to wait, I would be very smart. Right now, patients and families don't want to wait 10 years for me to be very smart. They'd like me to be very smart today." — Dr. Todd Levine [00:28:38 → 00:28:55] "So the biomarkers really are the big explosions. So the first biomarker was approved by the FDA for Alzheimer's disease last year. We've got more and more sophisticated biomarkers coming. And so really, almost anyone who's been diagnosed, you know, three plus years ago, unless they were in a research setting, probably did not have these tests. And as I said, we do know that the diagnosis is wrong about 30 or 40% of the time, regardless of how good the neurologist is, because we just haven't had the specific tools to be able to be confirmatory about our diagnosis." — Dr. Todd Levine [00:34:09 → 00:34:49] Dr. Todd Levine on LinkedIn -   / todd-levinemd   Neuro Concierge - https://neuro-concierge.com/ Podcast - https://what-id-tell-my-family.beam.ly/ What I´d Tell My Family Podcast on LinkedIn -   / what-id-tell-my-family   Podcast Partner - https://www.tophealth.care/ “Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”